Country’s pioneering scientific project GenomeIndia will yield the long-term benefit of reducing disease burden, thereby creating a healthier population in the country, said a renowned scientist on ...

In a historic announcement, Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science & Technology, ...

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 ...

Collectively, the data from in vitro and in vivo studies using FUS, TDP-43, and C9orf72 models demonstrate that hUPF1 holds significant potential for treating the majority of patients with ALS and ...

I traveled to the iconic Asilomar Conference Grounds in Monterey Bay as one of 50 “Next Generation Leaders” invited to take ...

A PDF of the poster presented at IAPRD 2025 30 th World Congress on Parkinson's Disease and Related Disorders is available on ...

Within just the first month of Expo 2025 in Osaka, Japan, the Thai Pavilion has welcomed over 200,000 visitors charmed by Thailand's fusion of cutting-edge innovation and rich cultural heritage.

The global AI In Life science Analytics Market is projected to be valued at USD 1.9 billion in 2024 and reach USD 3.6 billion ...

Kim Moon-soo, presidential candidate of the conservative People Power Party, on Friday vowed to relocate the National ...

Data update from ongoing TNG462 Phase 1/2 monotherapy trial expected 2H 2025 - - Combination trial of TNG462 + Revolution Medicines RAS(ON) inhibitors on track for enrollment 2Q 2025 - - Cash position ...

A dozen Canadian groups are leading exhibition at this year's Venice Biennale, which opened this month. Here's what they have ...

Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Ital ...